Pharma Journalist -

FORMA Therapeutics, Inc. (FORMA), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Vir Biotechnology, Inc. announced additional interim data from the ongoing Phase 2 trial in patients and results from the Phase 1 trial in healthy volunteers of VIR-2218, an…
Read More...

FUJIFILM Corporation has announced that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its influenza antiviral…
Read More...

TScan Therapeutics, a biopharmaceutical company focused on the development of T cell receptor (TCR) therapies which reprogram a patient’s own T cells to recognize shared cancer targets,…
Read More...

SMi reports: Registration is now open for the Oligonucleotide Therapeutics and Delivery Conference, which will convene in London on 16th – 17th September 2020. SMi Group are proud to…
Read More...

London – Arena International announced today that the Clinical Trial Supply Conference (https://arena-international.com/ctsvirtual/) will be held as a Virtual Experience on Tuesday, 12…
Read More...

London – Arena International announced today that the Outsourcing in Clinical Trials Conference (https://arena-international.com/octvirtual/) will be held as a Virtual Experience on…
Read More...

Merck, known as MSD outside the United States and Canada, announced the U.S. launch of ONTRUZANT (trastuzumab-dttb), as a biosimilar of the reference biologic medicine Herceptin.…
Read More...

Applied DNA Sciences Inc. announced that it has completed design qualification, production and shipment of five COVID-19 vaccine candidates to Italy-based Takis Biotech (“Takis”), a…
Read More...

IMMUNOPRECISE ANTIBODIES LTD. announced that it, through its subsidiary Talem Therapeutics, has entered into a research license agreement (the "Agreement") with Janssen Research &…
Read More...